• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经内镜与非内镜入路行结膜囊鼻腔吻合术(CDCR)的成功率和并发症:系统评价。

Conjunctivodacryocystorhinostomy (CDCR) success rates and complications in endoscopic vs non-endoscopic approaches: a systematic review.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel.

Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

出版信息

Int Forum Allergy Rhinol. 2021 Feb;11(2):174-194. doi: 10.1002/alr.22668. Epub 2020 Aug 6.

DOI:10.1002/alr.22668
PMID:32761875
Abstract

BACKGROUND

Epiphora due to refractory bicanalicular obstructions is typically managed by conjunctivodacryocystorhinostomy (CDCR) with or without the assistance of nasal endoscopy. However, the evidence for its benefit is unclear.

METHODS

A systematic review of the literature on the treatment of epiphora by CDCR was performed (March 1, 2018). All studies reporting original data on patients suffering from epiphora treated with CDCR surgery were included. Primary outcomes were success and satisfaction rates. Secondary outcomes were CDCR complications. A comparison was made between the results obtained in patients undergoing CDCR with vs without assistance of nasal endoscopy.

RESULTS

Fifty-four studies representing information on 2555 CDCR procedures were included in the systematic review. All the studies are case series, most of them retrospective. Lester Jones tube (LJT) is the most commonly used in CDCR (66.7%). The overall success rate with all studies included (n = 2555) was 88.9%; 90.8% (n = 890) in CDCR with assistance of nasal endoscope and 87.7% (n = 1575) in the non-endoscopic approach. The overall "tube displacement" rate, the most common complication, was 24.5% (n = 2522), 20.8% (n = 1575) tube displacement in CDCR with assistance of nasal endoscope vs 26.7% (n = 1575) in the non-endoscopic approach. Only 3 studies (5.5%) used patient-reported outcome measures (PROMs) to evaluate epiphora improvement. Due to the low level of evidence and the high bias of the studies, a meta-analysis was not performed.

CONCLUSION

Based on the data available in the literature, CDCR is considered an effective procedure for treating epiphora due to proximal obstruction. Controlled and qualitative studies are needed to clarify the significance of the endoscope's contribution to CDCR.

摘要

背景

由于难治性双管阻塞引起的溢泪症通常通过结膜囊鼻腔吻合术(CDCR)治疗,可辅以或不辅以鼻内窥镜。然而,其益处的证据并不明确。

方法

对 CDCR 治疗溢泪症的文献进行系统评价(2018 年 3 月 1 日)。所有报告接受 CDCR 手术治疗溢泪症的患者原始数据的研究均包括在内。主要结果是成功率和满意度。次要结果是 CDCR 并发症。比较了接受和不接受鼻内窥镜辅助的 CDCR 患者的结果。

结果

54 项研究代表了 2555 例 CDCR 手术的信息,被纳入系统评价。所有研究均为病例系列研究,其中大多数为回顾性研究。LesterJones 管(LJT)是 CDCR 中最常用的(66.7%)。纳入的所有研究(n=2555)的总体成功率为 88.9%;鼻内窥镜辅助 CDCR 的成功率为 90.8%(n=890),非内窥镜方法的成功率为 87.7%(n=1575)。最常见的并发症“管移位”的总体发生率为 24.5%(n=2522),鼻内窥镜辅助 CDCR 的管移位率为 20.8%(n=1575),非内窥镜方法的管移位率为 26.7%(n=1575)。仅有 3 项研究(5.5%)使用患者报告的结局测量(PROMs)来评估溢泪改善情况。由于证据水平低且研究偏倚高,因此未进行荟萃分析。

结论

根据文献中的现有数据,CDCR 被认为是治疗近端阻塞引起溢泪症的有效方法。需要进行对照和定性研究,以阐明内窥镜对 CDCR 的贡献的意义。

相似文献

1
Conjunctivodacryocystorhinostomy (CDCR) success rates and complications in endoscopic vs non-endoscopic approaches: a systematic review.经内镜与非内镜入路行结膜囊鼻腔吻合术(CDCR)的成功率和并发症:系统评价。
Int Forum Allergy Rhinol. 2021 Feb;11(2):174-194. doi: 10.1002/alr.22668. Epub 2020 Aug 6.
2
Clinical study of endoscopic endonasal conjunctivodacryocystorhinostomy with Jones tube placement.内镜下经鼻结膜泪囊鼻腔造口术联合琼斯管置入的临床研究
Ophthalmologica. 2007;221(1):36-40. doi: 10.1159/000096520.
3
Endoscopic conjunctivodacryocystorhinostomy with Jones tube placement.内镜下结膜泪囊鼻腔造口术并置入琼斯管
Ophthalmology. 2000 Jun;107(6):1206-9. doi: 10.1016/s0161-6420(00)00119-6.
4
The Effectiveness and Long-Term Outcome of Conjunctivodacryocystorhinostomy With Frosted Jones Tubes.带磨砂琼斯管的结膜泪囊鼻腔造口术的有效性及长期疗效
Ophthalmic Plast Reconstr Surg. 2017 Jul/Aug;33(4):294-299. doi: 10.1097/IOP.0000000000000764.
5
Modified conjunctivodacryocystorhinostomy for upper lacrimal system obstruction.改良结膜泪囊鼻腔造口术治疗上泪道系统阻塞
Arch Facial Plast Surg. 2007 Mar-Apr;9(2):96-100. doi: 10.1001/archfaci.9.2.96.
6
Selective partial middle turbinectomy to minimize postoperative obstruction following Lester Jones tube placement.选择性部分中鼻甲切除术,以尽量减少莱斯特·琼斯管置入术后的阻塞。
Am J Otolaryngol. 2015 May-Jun;36(3):330-3. doi: 10.1016/j.amjoto.2014.11.009. Epub 2014 Nov 27.
7
Results of a new "mirror tuck technique" for fixation of lacrimal bypass tube in conjunctivodacryocystorhinostomy.用于结膜泪囊鼻腔吻合术中泪道引流管固定的新型“镜像折叠技术”的结果
Indian J Ophthalmol. 2017 Apr;65(4):282-287. doi: 10.4103/ijo.IJO_741_16.
8
CDCR with buccal mucosal graft: comparative and histopathological study.带颊黏膜移植的阴茎头再造术:比较与组织病理学研究
Ophthalmic Surg Lasers. 1999 Feb;30(2):98-104.
9
Application of a symptoms score questionnaire after conjunctivodacryocystorhinostomy: outcomes.结膜囊鼻腔吻合术后症状评分问卷的应用:结果。
Acta Otorhinolaryngol Ital. 2021 Jun;41(3):248-254. doi: 10.14639/0392-100X-N0881.
10
A new modification in the porous polyethylene-coated lester jones tube.多孔聚乙烯涂层莱斯特·琼斯管的一种新改良。
Orbit. 2009;28(1):25-8. doi: 10.1080/01676830802414830.

引用本文的文献

1
Congenital Nasolacrimal Duct Obstruction: Natural Course, Diagnosis and Therapeutic Strategies.先天性鼻泪管阻塞:自然病程、诊断与治疗策略
J Clin Med. 2025 May 26;14(11):3716. doi: 10.3390/jcm14113716.
2
Surgical outcomes and management of complications of StopLoss Jones tube: a single-center study.止损琼斯管的手术效果及并发症处理:一项单中心研究
Int Ophthalmol. 2024 Dec 11;45(1):7. doi: 10.1007/s10792-024-03380-7.
3
Preliminary study on the efficacy of lacrimal duct reconstruction with pedicled conjunctival flap in the treatment of severe lacrimal canalicular obstruction with conjunctivochalasis.
带蒂结膜瓣泪道重建术治疗重度泪小管阻塞合并结膜松弛症疗效的初步研究
Int J Ophthalmol. 2023 Apr 18;16(4):539-546. doi: 10.18240/ijo.2023.04.07. eCollection 2023.
4
Lacrimal gland botulinum toxin injection for epiphora management.泪腺肉毒杆菌毒素注射治疗溢泪。
Orbit. 2022 Apr;41(2):150-161. doi: 10.1080/01676830.2021.1966810. Epub 2021 Aug 15.
5
Application of a symptoms score questionnaire after conjunctivodacryocystorhinostomy: outcomes.结膜囊鼻腔吻合术后症状评分问卷的应用:结果。
Acta Otorhinolaryngol Ital. 2021 Jun;41(3):248-254. doi: 10.14639/0392-100X-N0881.
6
Multidisciplinary approach to lacrimal system diseases.泪器系统疾病的多学科治疗方法。
Acta Otorhinolaryngol Ital. 2021 Apr;41(Suppl. 1):S102-S107. doi: 10.14639/0392-100X-suppl.1-41-2021-10.